Results 51 to 60 of about 211,280 (349)

Bleeding Risk of Cerebral Cavernous Malformations in Patients on Statin and Antiplatelet Medication: A Cohort Study. [PDF]

, 2023
BACKGROUND Statin medication has been identified as a potential therapeutic target for stabilizing cerebral cavernous malformations (CCMs). Although increasing evidence suggests that antiplatelet medication decreases the risk of CCM hemorrhage, data ...
Mattia Branca, Christian Jaeggi, Bervini, David, Johannes Goldberg, Jaeggi, Christian, Marques, Luca Lee, Branca, Mattia, Goldberg, Johannes, Luca Lee Marques, David Bervini, Raabe, Andreas, Andreas Raabe   +11 more
core   +1 more source

Secondary prevention of coronary heart disease in older patients after the national service framework: population based study [PDF]

, 2006
Objective To examine the extent of uptake of medication for secondary prevention of coronary heart disease in older British men and women before (1998-2001) and after (2003) the implementation of the national service framework.Design Two population based,
Morris, RW, Whincup, Peter H, Whincup, PH, Morris, Richard W, Papacosta, O, Ramsay, Sheena E, Ebrahim, S, Lawlor, Debbie A, Thomas, Mary C, Thomas, MC, Lennon, Lucy T, Lawlor, DA, Ramsay, SE, Lennon, LT, Ebrahim, Shah, Papacosta, Olia   +15 more
core   +1 more source

Challenges in the Management of Major Hemorrhage after Hemorrhoidal Banding

World Journal of Colorectal Surgery, 2021
Hemorrhoidal banding is considered a safe, low-risk technique for the management of grade-I–III internal hemorrhoids. Furthermore, information in the literature regarding serious complications associated with banding is limited.
Kabytto Chen, Michael Su, James W. T. Toh   +2 more
doaj   +1 more source

Congenital anomaly of coronary artery: absence of left circumflex artery

Journal of Community Hospital Internal Medicine Perspectives, 2019
The prevalence of congenital coronary artery anomalies is approximately 1% in the general population. They are a common cause of sudden death in younger persons. Congenital absence of the left circumflex artery is usually a benign condition but can cause
Muhammad Shabbir Rawala, Amna Saleem Ahmed, Muhammad Asif Iqbal, Ahsan Iqbal, Praveen Kumar Budde, Syed Bilal Rizvi   +5 more
doaj   +1 more source

Treatment inequity in antiplatelet therapy for ischaemic heart disease in patients with advanced chronic kidney disease: releasing the evidence vacuum

Platelets, 2023
Chronic kidney disease (CKD) is a global health problem and an independent risk factor for cardiovascular morbidity and mortality. Despite evidence-based therapies significantly improving cardiovascular mortality outcomes in the general population and ...
Frances L. Varian, William A. E. Parker, James Fotheringham, Robert F. Storey   +3 more
doaj   +1 more source

Twelve or 30 Months of Dual Antiplatelet Therapy After Drug-eluting Stents

New England Journal of Medicine, 2014
Background Dual antiplatelet therapy is recommended after coronary stenting to prevent thrombotic complications, yet the benefits and risks of treatment beyond 1 year are uncertain.
L. Mauri, D. Kereiakes, Robert W. Yeh, P. Driscoll-Shempp, D. Cutlip, P. Steg, Sharon-Lise T. Normand, E. Braunwald, S. Wiviott, David J. Cohen, David R. Holmes, M. Krucoff, James B. Hermiller, H. Dauerman, Daniel I. Simon, D. Kandzari, Kirk N. Garratt, David P. Lee, Thomas K. Pow, P. V. Ver Lee, Michael J. Rinaldi, Joseph M. Massaro   +21 more
semanticscholar   +1 more source

European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA

European Stroke Journal, 2021
Prevention of early recurrent ischaemic stroke remains a priority in people with TIA or ischaemic stroke. A number of trials have recently been completed assessing the efficacy of short-term dual antiplatelet therapy (DAPT) versus single antiplatelet ...
J. Dawson, Á. Merwick, A. Webb, M. Dennis, J. Ferrari, Ana Catarina Fonseca   +5 more
semanticscholar   +1 more source

The Emerging Role of Platelets in the Formation of the Micrometastatic Niche: Current Evidence and Future Perspectives

Frontiers in Oncology, 2020
Accumulating evidence suggests that platelets play a key role in cancer metastatic dissemination through their multilevel interaction with tumor cells. Most crucial is the contribution of platelets to the formation and expansion of the early metastatic ...
Stavros Gkolfinopoulos, Robin L. Jones, Anastasia Constantinidou, Anastasia Constantinidou, Anastasia Constantinidou   +4 more
doaj   +1 more source

Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases

Platelets, 2021
Antiplatelet medications comprise the cornerstone of treatment for diseases that involve arterial thrombosis, including acute coronary syndromes (ACS), stroke and peripheral arterial disease.
Maan H. Harbi, Christopher W. Smith, Phillip L. R. Nicolson, Steve P. Watson, Mark R. Thomas   +4 more
doaj   +1 more source

Antiplatelet and Antithrombotic Activities of Non-Steroidal Anti-Inflammatory Drugs Containing an N-Acyl Hydrazone Subunit

Molecules, 2014
Nonsteroidal anti-inflammatory drugs (NSAIDs) 1–5 containing an N-acyl hydrazone subunit were prepared and their antiplatelet and antithrombotic activities assessed in vitro and in vivo.
Rafael Consolin Chelucci, Luiz Antônio Dutra, Maria Elisa Lopes Pires, Thais Regina Ferreira de Melo, Priscila Longhin Bosquesi, Man Chin Chung, Jean Leandro dos Santos   +6 more
doaj   +1 more source